Sundu Brahamasandra

Sundu serves as the President of NeuMoDx Molecular. Most recently, he served as the President of Life Magnetics, Inc. a spin-out from the University of Michigan developing a novel, non-microscope based platform for real-time monitoring of cell growth, death and other binding events. Prior to Life Magnetics, Sundu served as a VP of R&D/Assay Development in the Infectious Disease division at BD Diagnostics. Prior to BD, Sundu was Co-Founder and V.P. Product Development of HandyLab, Inc., where he led the development & validation of the Jaguar molecular diagnostic platform as well as proprietary nucleic acid preparation technologies and a multitude of real-time PCR assays spanning molecular diagnostics, food-borne pathogen detection, GMO testing and other applications. HandyLab was acquired by BD in Nov 2009 for more than $275 million.

Sundu received his BS from the Indian Institute of Technology, Chennai and a PhD in Chemical Engineering from the University of Michigan in 2001.